Bulk Rituximab Immunological Product from United States
Bulk Rituximab is a chimeric monoclonal antibody targeting CD20 on B-cells, used in lymphoma and autoimmune disease therapy. It is an unmixed immunological product produced via biotechnological processes, not for retail sale, and is classified under 3002.13.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is in bulk form without any measured doses or retail packaging
• Provide evidence of biotechnological production methods
• Verify if an import permit from Health Canada is needed for the active substance